Contrasting effects of haloperidol and lithium on rodent brain structure: A magnetic resonance imaging study with postmortem confirmation

Biological Psychiatry

Volumn 71, Issue 10, 2012, Pages 855-863

  Vernon, Anthony C ^a   Natesan, Sridhar ^a   Crum, William R ^a   Cooper, Jonathan D ^a   Modo, Michel ^a   Williams, Steven C R ^a   Kapur, Shitij ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Antipsychotic; brain volume; haloperidol; lithium; magnetic resonance imaging; schizophrenia

Indexed keywords

HALOPERIDOL; LITHIUM;

ARTICLE; AUTOPSY; BRAIN SIZE; CORPUS STRIATUM; GRAY MATTER; HYPERTROPHY; IN VIVO STUDY; INFERIOR CEREBELLAR PEDUNCLE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SUPERIOR CEREBELLAR PEDUNCLE; TREATMENT DURATION;

ANIMALS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; BRAIN; HALOPERIDOL; LITHIUM COMPOUNDS; MAGNETIC RESONANCE IMAGING; MALE; MODELS, ANIMAL; ORGAN SIZE; RATS; RATS, SPRAGUE-DAWLEY; SCHIZOPHRENIA;

EID: 84863404151     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2011.12.004     Document Type: Article

References (60)

1. B.C. Ho, N.C. Andreasen, S. Ziebell, R. Pierson, V. Magnotta Long-term antipsychotic treatment and brain volumes: A longitudinal study of first-episode schizophrenia Arch Gen Psychiatry 68 2011 128 137
2. J.A. Lieberman, G.D. Tollefson, C. Charles, R. Zipursky, T. Sharma, R.S. Kahn Antipsychotic drug effects on brain morphology in first-episode psychosis Arch Gen Psychiatry 62 2005 361 370
3. I.K. Lyoo, S.R. Dager, J.E. Kim, S.J. Yoon, S.D. Friedman, D.L. Dunner Lithium-induced gray matter volume increase as a neural correlate of treatment response in bipolar disorder: A longitudinal brain imaging study Neuropsychopharmacology 35 2010 1743 1750
4. G.J. Moore, J.M. Bebchuk, I.B. Wilds, G. Chen, H.K. Manji Lithium-induced increase in human brain grey matter Lancet 356 2000 1241 1242
5. M.H. Chakos, J.A. Lieberman, R.M. Bilder, M. Borenstein, G. Lerner, B. Bogerts Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs Am J Psychiatry 151 1994 1430 1436
6. P. Dazzan, K.D. Morgan, K. Orr, G. Hutchinson, X. Chitnis, J. Suckling Different effects of typical and atypical antipsychotics on grey matter in first episode psychosis: the AESOP study Neuropsychopharmacology 30 2005 765 774
7. M.S. Keshavan, W.W. Bagwell, G.L. Haas, J.A. Sweeney, N.R. Schooler, J.W. Pettegrew Changes in caudate volume with neuroleptic treatment Lancet 344 1994 1434
8. H. Tost, D.F. Braus, S. Hakimi, M. Ruf, C. Vollmert, F. Hohn Acute D2 receptor blockade induces rapid, reversible remodeling in human cortical-striatal circuits Nat Neurosci 13 2010 920 922
9. W. Cahn, H.E. Hulshoff Pol, E.B. Lems, N.E. van Haren, H.G. Schnack, J.A. van der Linden Brain volume changes in first-episode schizophrenia: A 1-year follow-up study Arch Gen Psychiatry 59 2002 1002 1010
10. N.E. van Haren, H.E. Hulshoff Pol, H.G. Schnack, W. Cahn, R. Brans, I. Carati Progressive brain volume loss in schizophrenia over the course of the illness: Evidence of maturational abnormalities in early adulthood Biol Psychiatry 63 2008 106 113
11. N.E. van Haren, H.G. Schnack, W. Cahn, M.P. van den Heuvel, C. Lepage, L. Collins Changes in cortical thickness during the course of illness in schizophrenia Arch Gen Psychiatry 68 2011 871 880
12. G.J. Moore, B.M. Cortese, D.A. Glitz, C. Zajac-Benitez, J.A. Quiroz, T.W. Uhde A longitudinal study of the effects of lithium treatment on prefrontal and subgenual prefrontal gray matter volume in treatment-responsive bipolar disorder patients J Clin Psychiatry 70 2009 699 705
13. R.B. Sassi, M. Nicoletti, P. Brambilla, A.G. Mallinger, E. Frank, D.J. Kupfer Increased gray matter volume in lithium-treated bipolar disorder patients Neurosci Lett 329 2002 243 245
14. K. Yucel, M.C. McKinnon, V.H. Taylor, K. Macdonald, M. Alda, L.T. Young Bilateral hippocampal volume increases after long-term lithium treatment in patients with bipolar disorder: A longitudinal MRI study Psychopharmacology (Berl) 195 2007 357 367
15. K. Yucel, V.H. Taylor, M.C. McKinnon, K. Macdonald, M. Alda, L.T. Young Bilateral hippocampal volume increase in patients with bipolar disorder and short-term lithium treatment Neuropsychopharmacology 33 2008 361 367
16. S. Kapur, S.C. VanderSpek, B.A. Brownlee, J.N. Nobrega Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: A suggested solution based on in vivo occupancy J Pharmacol Exp Ther 305 2003 625 631
17. R. McQuade, M.M. Leitch, S.E. Gartside, A.H. Young Effect of chronic lithium treatment on glucocorticoid and 5-HT1A receptor messenger RNA in hippocampal and dorsal raphe nucleus regions of the rat brain J Psychopharmacol 18 2004 496 501
18. K.C. O'Donnell, T.D. Gould The behavioral actions of lithium in rodent models: leads to develop novel therapeutics Neurosci Biobehav Rev 31 2007 932 962
19. A.C. Vernon, S. Natesan, M. Modo, S. Kapur Effect of chronic antipsychotic treatment on brain structure: A serial magnetic resonance imaging study with ex vivo and postmortem confirmation Biol Psychiatry 69 2011 936 944
20. R. Quinn Comparing rat's to human's age: How old is my rat in people years? Nutrition 21 2005 775 777
21. P. Turrone, G. Remington, S. Kapur, J.N. Nobrega The relationship between dopamine D2 receptor occupancy and the vacuous chewing movement syndrome in rats Psychopharmacology (Berl) 165 2003 166 171
22. L. Ferrie, A.H. Young, R. McQuade Effect of lithium and lithium withdrawal on potassium-evoked dopamine release and tyrosine hydroxylase expression in the rat Int J Neuropsychopharmacol 9 2006 729 735
23. J. Scott, M. Pope Self-reported adherence to treatment with mood stabilizers, plasma levels, and psychiatric hospitalization Am J Psychiatry 159 2002 1927 1929
24. Joint Formulary Committee British National Formulary (BNF) 61st ed. 2011 BMJ Publishing Group Ltd and Royal Pharmaceutical Society London
25. A.C. Vernon, W.R. Crum, S.M. Johansson, M. Modo Evolution of extra-nigral damage predicts behavioural deficits in a rat proteasome inhibitor model of Parkinson's disease PLoS One 6 2011 e17269
26. G. Paxinos, C. Watson The Rat Brain in Stereotaxic Coordinates 6th ed. 2007 Academic Press San Deigo, CA
27. O.T. Wolf, V. Dyakin, C. Vadasz, M.J. de Leon, B.S. McEwen, K. Bulloch Volumetric measurement of the hippocampus, the anterior cingulate cortex, and the retrosplenial granular cortex of the rat using structural MRI Brain Res Brain Res Protoc 10 2002 41 46
28. C. Kielar, L. Maddox, E. Bible, C.C. Pontikis, S.L. Macauley, M.A. Griffey Successive neuron loss in the thalamus and cortex in a mouse model of infantile neuronal ceroid lipofuscinosis Neurobiol Dis 25 2007 150 162
29. H.J. Gundersen, E.B. Jensen The efficiency of systematic sampling in stereology and its prediction J Microsc 147 1987 229 263
30. M.J. West, L. Slomianka, H.J. Gundersen Unbiased stereological estimation of the total number of neurons in thesubdivisions of the rat hippocampus using the optical fractionator Anat Rec 231 1991 482 497
31. P.M. Thompson, G. Bartzokis, K.M. Hayashi, A.D. Klunder, P.H. Lu, N. Edwards Time-lapse mapping of cortical changes in schizophrenia with different treatments Cereb Cortex 19 2009 1107 1123
32. C. Andersson, R.M. Hamer, C.P. Lawler, R.B. Mailman, J.A. Lieberman Striatal volume changes in the rat following long-term administration of typical and atypical antipsychotic drugs Neuropsychopharmacology 27 2002 143 151
33. M.H. Chakos, O. Shirakawa, J. Lieberman, H. Lee, R. Bilder, C.A. Tamminga Striatal enlargement in rats chronically treated with neuroleptic Biol Psychiatry 44 1998 675 684
34. S. Kapur, R. Zipursky, P. Roy, C. Jones, G. Remington, K. Reed The relationship between D2 receptor occupancy and plasma levels on low dose oral haloperidol: A PET study Psychopharmacology 131 1997 148 152
35. I.C. Wright, S. Rabe-Hesketh, P.W. Woodruff, A.S. David, R.M. Murray, E.T. Bullmore Meta-analysis of regional brain volumes in schizophrenia Am J Psychiatry 157 2000 16 25
36. M.J. Kempton, D. Stahl, S.C. Williams, L.E. DeLisi Progressive lateral ventricular enlargement in schizophrenia: A meta-analysis of longitudinal MRI studies Schizophr Res 120 2010 54 62
37. P.J. Harrison The neuropathology of schizophrenia A critical review of the data and their interpretation Brain 122 1999 593 624
38. E.S. Monkul, K. Matsuo, M.A. Nicoletti, N. Dierschke, J.P. Hatch, M. Dalwani Prefrontal gray matter increases in healthy individuals after lithium treatment: A voxel-based morphometry study Neurosci Lett 429 2007 7 11
39. B. Hallahan, J. Newell, J.C. Soares, P. Brambilla, S.M. Strakowski, D.E. Fleck Structural magnetic resonance imaging in bipolar disorder: An international collaborative mega-analysis of individual adult patient data Biol Psychiatry 69 2011 326 335
40. M.J. Kempton, J.R. Geddes, U. Ettinger, S.C. Williams, P.M. Grasby Meta-analysis, database, and meta-regression of 98 structural imaging studies in bipolar disorder Arch Gen Psychiatry 65 2008 1017 1032
41. C.E. Bearden, P.M. Thompson, M. Dalwani, K.M. Hayashi, A.D. Lee, M. Nicoletti Greater cortical gray matter density in lithium-treated patients with bipolar disorder Biol Psychiatry 62 2007 7 16
42. C.E. Bearden, P.M. Thompson, R.A. Dutton, B.N. Frey, M.A. Peluso, M. Nicoletti Three-dimensional mapping of hippocampal anatomy in unmedicated and lithium-treated patients with bipolar disorder Neuropsychopharmacology 33 2008 1229 1238
43. F.M. Benes, P.A. Paskevich, J. Davidson, V.B. Domesick The effects of haloperidol on synaptic patterns in the rat striatum Brain Res 329 1985 265 273
44. C. Konradi, S. Heckers Antipsychotic drugs and neuroplasticity: Insights into the treatment and neurobiology of schizophrenia Biol Psychiatry 50 2001 729 742
45. G. Boonstra, N.E. van Haren, H.G. Schnack, W. Cahn, H. Burger, M. Boersma Brain volume changes after withdrawal of atypical antipsychotics in patients with first-episode schizophrenia J Clin Psychopharmacol 31 2011 146 153
46. N.C. Andreasen, P. Nopoulos, V. Magnotta, R. Pierson, S. Ziebell, B.C. Ho Progressive brain change in schizophrenia: A prospective longitudinal study of first-episode schizophrenia Biol Psychiatry 70 2011 672 679
47. B. Olabi, I. Ellison-Wright, A.M. McIntosh, S.J. Wood, E. Bullmore, S.M. Lawrie Are there progressive brain changes in schizophrenia? A meta-analysis of structural magnetic resonance imaging studies Biol Psychiatry 70 2011 88 96
48. S. Edelfors The influence of lithium on water binding ability, consistency and macromolecules in the rat brain Acta Pharmacol Toxicol (Copenh) 40 1977 126 133
49. P. Phatak, A. Shaldivin, L.S. King, P. Shapiro, W.T. Regenold Lithium and inositol: Effects on brain water homeostasis in the rat Psychopharmacology (Berl) 186 2006 41 47
50. S. Kapur, D. Mamo Half a century of antipsychotics and still a central role for dopamine D2 receptors Prog Neuropsychopharmacol Biol Psychiatry 27 2003 1081 1090
51. A.N. Samaha, P. Seeman, J. Stewart, H. Rajabi, S. Kapur "Breakthrough" dopamine supersensitivity during ongoing antipsychotic treatment leads to treatment failure over time J Neurosci 27 2007 2979 2986
52. M.R. Martins, F.C. Petronilho, K.M. Gomes, F. Dal-Pizzol, E.L. Streck, J. Quevedo Antipsychotic-induced oxidative stress in rat brain Neurotox Res 13 2008 63 69
53. J.M. Beaulieu, E. Tirotta, T.D. Sotnikova, B. Masri, A. Salahpour, R.R. Gainetdinov Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo J Neurosci 27 2007 881 885
54. G.T. Konopaske, K.A. Dorph-Petersen, J.N. Pierri, Q. Wu, A.R. Sampson, D.A. Lewis Effect of chronic exposure to antipsychotic medication on cell numbers in the parietal cortex of macaque monkeys Neuropsychopharmacology 32 2007 1216 1223
55. G.T. Konopaske, K.A. Dorph-Petersen, R.A. Sweet, J.N. Pierri, W. Zhang, A.R. Sampson Effect of chronic antipsychotic exposure on astrocyte and oligodendrocyte numbers in macaque monkeys Biol Psychiatry 63 2008 759 765
56. L.D. Selemon, P.S. Goldman-Rakic The reduced neuropil hypothesis: A circuit based model of schizophrenia Biol Psychiatry 45 1999 17 25
57. H.K. Manji, G.J. Moore, G. Chen Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: a role for neurotrophic and neuroprotective effects in manic depressive illness J Clin Psychiatry 61 9 suppl 2000 82 96
58. J.A. Quiroz, R. Machado-Vieira, C.A. Zarate Jr, H.K. Manji Novel insights into lithium's mechanism of action: Neurotrophic and neuroprotective effects Neuropsychobiology 62 2010 50 60
59. Y. Piontkewitz, Y. Assaf, I. Weiner Clozapine administration in adolescence prevents postpubertal emergence of brain structural pathology in an animal model of schizophrenia Biol Psychiatry 66 2009 1038 1046
60. J. Ashburner, J.G. Csernansky, C. Davatzikos, N.C. Fox, G.B. Frisoni, P.M. Thompson Computer-assisted imaging to assess brain structure in healthy and diseased brains Lancet Neurol 2 2003 79 88